rs72650764

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_213655.5(WNK1):​c.6607A>G​(p.Thr2203Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000413 in 1,614,106 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T2203I) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.00018 ( 0 hom., cov: 29)
Exomes š‘“: 0.00044 ( 1 hom. )

Consequence

WNK1
NM_213655.5 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:3

Conservation

PhyloP100: 1.95

Publications

4 publications found
Variant links:
Genes affected
WNK1 (HGNC:14540): (WNK lysine deficient protein kinase 1) This gene encodes a member of the WNK subfamily of serine/threonine protein kinases. The encoded protein may be a key regulator of blood pressure by controlling the transport of sodium and chloride ions. Mutations in this gene have been associated with pseudohypoaldosteronism type II and hereditary sensory neuropathy type II. Alternatively spliced transcript variants encoding different isoforms have been described but the full-length nature of all of them has yet to be determined.[provided by RefSeq, May 2010]
WNK1 Gene-Disease associations (from GenCC):
  • neuropathy, hereditary sensory and autonomic, type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Ambry Genetics
  • pseudohypoaldosteronism type 2C
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.15734893).
BP6
Variant 12-896338-A-G is Benign according to our data. Variant chr12-896338-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 571493.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WNK1NM_213655.5 linkc.6607A>G p.Thr2203Ala missense_variant Exon 24 of 28 ENST00000340908.9 NP_998820.3 Q9H4A3-5
WNK1NM_018979.4 linkc.5851A>G p.Thr1951Ala missense_variant Exon 24 of 28 ENST00000315939.11 NP_061852.3 Q9H4A3-1A5D8Z4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WNK1ENST00000340908.9 linkc.6607A>G p.Thr2203Ala missense_variant Exon 24 of 28 5 NM_213655.5 ENSP00000341292.5 Q9H4A3-5
WNK1ENST00000315939.11 linkc.5851A>G p.Thr1951Ala missense_variant Exon 24 of 28 1 NM_018979.4 ENSP00000313059.6 Q9H4A3-1

Frequencies

GnomAD3 genomes
AF:
0.000184
AC:
28
AN:
152214
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000397
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000135
AC:
34
AN:
251326
AF XY:
0.000125
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000273
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000436
AC:
638
AN:
1461892
Hom.:
1
Cov.:
31
AF XY:
0.000428
AC XY:
311
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.000119
AC:
4
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000549
AC:
611
AN:
1112010
Other (OTH)
AF:
0.000348
AC:
21
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
46
91
137
182
228
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000184
AC:
28
AN:
152214
Hom.:
0
Cov.:
29
AF XY:
0.000148
AC XY:
11
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41448
American (AMR)
AF:
0.00
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000397
AC:
27
AN:
68040
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000350
Hom.:
0
Bravo
AF:
0.000208
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000157
AC:
19
EpiCase
AF:
0.000545
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Pseudohypoaldosteronism type 2C;C2752089:Neuropathy, hereditary sensory and autonomic, type 2A Uncertain:1Benign:1
Apr 19, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1Benign:1
Sep 06, 2023
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is higher than would generally be expected for pathogenic variants in this gene (http://gnomad.broadinstitute.org). In some published literature, this variant is referred to as c.5851A>G (p.T1951A). Computational tools disagree on the variant's effect on normal protein function. -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

WNK1: BP4, BS1:Supporting -

Inborn genetic diseases Uncertain:1
Jun 25, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.T2203A variant (also known as c.6607A>G), located in coding exon 24 of the WNK1 gene, results from an A to G substitution at nucleotide position 6607. The threonine at codon 2203 is replaced by alanine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species; however, alanine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Pseudohypoaldosteronism type 2C Benign:1
Nov 15, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
17
DANN
Benign
0.85
DEOGEN2
Benign
0.13
T;.;D;.;.
Eigen
Benign
0.12
Eigen_PC
Benign
0.082
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Benign
0.79
T;T;T;T;T
M_CAP
Uncertain
0.093
D
MetaRNN
Benign
0.16
T;T;T;T;T
MetaSVM
Benign
-0.31
T
MutationAssessor
Uncertain
2.1
.;.;M;.;.
PhyloP100
1.9
PrimateAI
Benign
0.34
T
PROVEAN
Uncertain
-3.1
D;.;D;.;D
REVEL
Benign
0.26
Sift
Uncertain
0.018
D;.;D;.;D
Sift4G
Uncertain
0.028
D;.;D;D;D
Polyphen
0.99
D;.;D;.;.
Vest4
0.24
MVP
0.37
MPC
0.12
ClinPred
0.19
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.17
gMVP
0.098
Mutation Taster
=80/20
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72650764; hg19: chr12-1005504; API